| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.019 | 0.5 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |